Why Recursion Pharmaceuticals Stock Is Sinking Today
Shares of Recursion Pharmaceuticals (RXRX -6.22%) were sinking 8.2% lower as of 10:57 a.m. ET on Monday. The clinical-stage biotech company, which is a pioneer in using artificial intelligence (AI) in drug discovery, didn’t announce any news that would cause its stock to fall,
» Read more about: Why Recursion Pharmaceuticals Stock Is Sinking Today »
Read MoreThe Burst
2 Cathie Wood Bargains (with HUGE Upside)
It’s no secret that Cathie Wood’s collection of ARK funds have had a horrendous 2022. Her ARKK flagship fund was down 53% year-to-date at the time of writing and traded in the mid-$30s as recently as June, down from a high of almost $100 per share at the start of the year.
But there’s light at the end of the tunnel for growth investors.
» Read more about: 2 Cathie Wood Bargains (with HUGE Upside) »
Read MoreThe Ivy
Alert: 27.6% Upside in Technical Breakout?
Investment Alert: Buy BYND Under $13.10/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Usually we like to find fundamentally undervalued stocks that have a proven track record of growing through thick and thin.
» Read more about: Alert: 27.6% Upside in Technical Breakout? »
Read More